Janvrit

Read what matters.

1 min read

Kratom and Concentrated 7-OH Products Are Not Interchangeable

A plant-based label can conceal important differences in composition, concentration and risk.

AI illustration: Botanical study of fresh kratom leaves on a branch beside a sealed plain container, neutral informative still life, no medicinal claims or consumption.
AI-generated conceptual illustration; not a photograph of a real event. · AI-generated for Janvrit using OpenAI ImageGen

Two products can mention kratom while delivering very different substances and concentrations. That is one reason broad claims that kratom is simply “natural” or “safe” are unreliable.

Kratom comes from a plant, but products sold under related labels are not all equivalent. US FDA warnings distinguish concerns about kratom from the risks of products containing concentrated 7-hydroxymitragynine, often shortened to 7-OH.

Concentration changes the question

An ingredient’s presence in a leaf does not establish the safety of a concentrated commercial preparation. The dose, other ingredients and consistency of manufacturing all matter.

The FDA warns that 7-OH products can cause serious harm. A package presented as a wellness product should not be mistaken for evidence that it has been approved as a medicine or shown safe for self-treatment.

Rules differ between countries and can change. A product being available online does not establish that importing or possessing it is legal where you live. Check the relevant regulator rather than a seller’s assurance, and seek medical advice about exposure or symptoms instead of relying on dosing advice from a product review.

Sources and further reading

fda.gov — fda and kratom

fda.gov — products containing 7 oh can cause serious harm